Parameter | Time point | Erythritol group (n=14) | Xylitol group (n=14) | Control group (n=14) | Time effect (P value) | Treatment effect (P value) |
Q1: Abdominal pain (pain or discomfort in the upper abdomen) | Preintervention | 1.2±0.4 | 1.4±0.9 | 1.1±0.4 | 0.108 | 0.390 |
Week 2 of intervention | 1.6±1.6 | 1.6±1.1 | 1.8±0.9 | |||
Week 4 of intervention | 1.3±0.8 | 1.6±1.0 | 1.9±1.4 | |||
Q2: Reflux (heart burn) | Preintervention | 1.1±0.4 | 1.7±1.3 | 1.4±0.6 | 0.560 | 0.015* (C vs E) |
Week 2 of intervention | 1.3±0.5 | 1.5±0.9 | 1.3±0.6 | |||
Week 4 of intervention | 1.1±0.5 | 1.6±1.0 | 1.8±1.2 | |||
Q3: Reflux (acid reflux) | Preintervention | 1.1±0.4 | 1.4±1.1 | 1.4±0.8 | 0.872 | 0.531 |
Week 2 of intervention | 1.4±0.7 | 1.3±0.6 | 1.2±0.4 | |||
Week 4 of intervention | 1.3±0.8 | 1.2±0.6 | 1.6±0.9 | |||
Q4: Abdominal pain (hunger pains) | Preintervention | 1.9±0.9 | 2.7±1.4 | 2.2±1.5 | 0.813 | 0.141 |
Week 2 of intervention | 2.1±1.4 | 2.7±1.4 | 2.6±1.5 | |||
Week 4 of intervention | 1.8±1.1 | 2.6±1.3 | 2.2±1.0 | |||
Q5: Abdominal pain (nausea) | Preintervention | 1.0±0.0 | 1.4±0.8 | 1.3±0.7 | 0.261 | 0.480 |
Week 2 of intervention | 1.6±1.4 | 1.5±1.2 | 1.2±0.4 | |||
Week 4 of intervention | 1.3±0.8 | 1.7±1.3 | 1.6±1.0 | |||
Q6: Indigestion (rumbling in the stomach) | Preintervention | 1.8±1.1 | 2.2±1.1 | 2.0±1.6 | 0.170 | 0.113 |
Week 2 of intervention | 1.7±0.9 | 2.5±1.3 | 2.6±1.7 | |||
Week 4 of intervention | 1.4±0.6 | 2.6±1.8 | 1.8±1.3 | |||
Q7: Indigestion (bloating) | Preintervention | 2.5±1.8 | 2.4±1.5 | 2.1±1.4 | 0.807 | 0.442 |
Week 2 of intervention | 2.1±1.9 | 2.8±1.9 | 2.2±1.4 | |||
Week 4 of intervention | 1.7±1.1 | 2.7±1.8 | 2.4±1.9 | |||
Q8: Indigestion (burping) | Preintervention | 1.6±0.8 | 2.1±1.3 | 1.9±1.2 | 0.436 | 0.079 |
Week 2 of intervention | 1.5±0.9 | 1.9±1.3 | 2.0±1.3 | |||
Week 4 of intervention | 1.3±0.6 | 2.1±1.4 | 2.5±2.0 | |||
Q9: Indigestion (passing gas/flatus) | Preintervention | 2.4±1.4 | 2.9±1.4 | 2.5±1.1 | 0.935 | 0.482 |
Week 2 of intervention | 2.6±1.7 | 2.9±1.7 | 2.4±1.5 | |||
Week 4 of intervention | 2.2±1.2 | 2.9±1.9 | 2.8±1.9 | |||
Q10: Constipation (reduced emptying) | Preintervention | 1.0±0.0 | 1.5±1.3 | 2.1±1.4 | 0.701 | 0.159 |
Week 2 of intervention | 1.6±1.3 | 1.8±1.5 | 1.6±0.9 | |||
Week 4 of intervention | 1.1±0.5 | 2.0±1.9 | 1.5±1.2 | |||
Q11: Diarrhoea (frequent emptying) | Preintervention | 1.4±0.7 | 1.6±0.9 | 1.9±1.0 | 0.212 | 0.236 |
Week 2 of intervention | 1.9±1.2 | 2.4±1.7 | 1.2±0.6 | |||
Week 4 of intervention | 1.7±0.8 | 2.1±1.6 | 2.3±1.3 | |||
Q12: Diarrhoea (loose stools) | Preintervention | 1.4±0.9 | 1.6±0.9 | 2.1±1.2 | 0.297 | 0.022* (E vs X) |
Week 2 of intervention | 1.4±0.6 | 2.9±2.1 | 1.5±0.8 | |||
Week 4 of intervention | 1.5±0.8 | 2.5±2.0 | 2.4±1.8 | |||
Q13: Constipation (hard stools) | Preintervention | 1.2±0.8 | 1.7±1.4 | 1.9±1.3 | 0.563 | 0.630 |
Week 2 of intervention | 1.9±1.4 | 1.4±0.9 | 1.9±1.3 | |||
Week 4 of intervention | 1.4±0.6 | 1.9±1.2 | 1.4±0.8 | |||
Q14: Diarrhoea (urgent need of bowel movement) | Preintervention | 1.4±0.5 | 1.1±0.5 | 1.4±0.6 | 0.006** (pre vs W2) | 0.262 |
Week 2 of intervention | 1.6±0.9 | 2.7±1.9 | 1.5±0.8 | |||
Week 4 of intervention | 1.6±1.0 | 2.4±2.2 | 2.1±1.8 | |||
Q15: Diarrhoea (incomplete emptying) | Removed from the analysis due to many missing values |
Linear mixed effect model with subsequent Šidak test.
**Significant with p<0.01; *significant with p<0.05.
C, control group; E, erythritol group; W2, week 2; X, xylitol group.